ListedSMEZENITHDRUG
Zenith Drugs Limited
Zenith Drugs Limited is a sme IPO raising ₹41 Cr at ₹75 – ₹79 a share. It listed on 27 Feb 2024 and trades at ₹51 today, −35.4% against its issue price of ₹79. It was subscribed 0.00× in total.
₹79
Issue price
₹51
Price now
−35.4%
Since issue price
27 Feb 2024
Listed on
0.00×Subscribed (final) · all exchanges
No bids yet
populated partly populated we hold nothing here — the tab says why
Who bid for it
| Investor category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| QIB Banks, funds and other large institutions | 0 | 9,16,97,600 | 0.00× |
| Foreign Institutional Investors | no separate quota | 4,54,32,000 | n/a |
| Domestic Financial Institutions | no separate quota | 47,28,000 | n/a |
| Mutual funds | no separate quota | 0 | n/a |
| Others | no separate quota | 4,15,37,600 | n/a |
| Non-institutional Wealthy individuals and companies bidding above ₹2 lakh | 0 | 23,85,39,200 | 0.00× |
| Corporates | no separate quota | 1,89,85,600 | n/a |
| Individuals | no separate quota | 20,23,15,200 | n/a |
| others | no separate quota | 1,72,38,400 | n/a |
| Retail Ordinary investors bidding up to ₹2 lakh | 0 | 20,84,04,800 | 0.00× |
| Cut Off | no separate quota | 11,70,56,000 | n/a |
| Price bids | no separate quota | 9,13,48,800 | n/a |
| Total | 0 | 53,86,41,600 | 0.00× |
Sub-categories read no separate quota rather than a dash: the exchange publishes bids at that level but never a reservation against them, so a subscription multiple does not exist — it is not missing data. Bids across both exchanges (NSE and BSE) — the figure usually quoted publicly. Last updated 25 Jul, 06:59 pm IST.
How demand built
We hold no subscription readings for this issue.